0001471363-25-000003.txt : 20250730 0001471363-25-000003.hdr.sgml : 20250730 20250730160113 ACCESSION NUMBER: 0001471363-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250730 DATE AS OF CHANGE: 20250730 EFFECTIVENESS DATE: 20250730 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BACCH Laboratories, Inc. CENTRAL INDEX KEY: 0001471363 ORGANIZATION NAME: EIN: 800309424 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-553252 FILM NUMBER: 251166867 BUSINESS ADDRESS: STREET 1: 747 SW 2ND AVENUE, IMB#11 CITY: GAINESVILE STATE: FL ZIP: 32601 BUSINESS PHONE: 352-870-3799 MAIL ADDRESS: STREET 1: 747 SW 2ND AVENUE, IMB#11 CITY: GAINESVILE STATE: FL ZIP: 32601 FORMER COMPANY: FORMER CONFORMED NAME: Bit Cauldron Corp DATE OF NAME CHANGE: 20090831 D 1 primary_doc.xml X0708 D LIVE 0001471363 BACCH Laboratories, Inc. 747 SW 2ND AVENUE, IMB#11 GAINESVILE FL FLORIDA 32601 352-870-3799 DELAWARE Bit Cauldron Corp Corporation true James Mentz c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Executive Officer Director Richard Allen c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Director Robert Mentz c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Executive Officer Benjamin Andrew Hoover c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Director Garrett Gleim c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Director Edgar Choueiri c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Executive Officer Director Other Technology Decline to Disclose 06b false 2024-03-25 true true true false 0 1000000 810000 190000 false 14 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director, manager or promoter will receive any payments from the proceeds of this offering. false BACCH Laboratories, Inc. /s/ Robert Mentz Robert Mentz Chief Financial Officer 2025-07-29